BB drugs Flashcards
TCAs
Imipramine
Amitriptyline
TCA MoAs, AEs
Inhibit reuptake of amines
Also affinity for H1, M3, a1 and a2 receptors
AEs = anticholinergic effects (dry mouth, constipation, urinary retention), weight gain, arrhythmia, dizziness
MAOIs
Phenelzine
Iproniazid
MAOI MoAs, AEs
Irreversible inhibition of MAO enzymes (non-selective)
Treatment of atypical depression
AEs = cheese reaction (with tyramine containing foods), hepatotoxicity
SSRIs
Citaopram
Fluoxetine
Sertraline
Paroxetine
SSRI MoA, AEs
Inhibition of serotonin reuptake No anticholinergic activity No cardiotoxic effects Safe in overdose AEs = nausea, headache, GI upset, anxiety, loss of libodi
Moclobemide
Reversible MAOa inhibitor
Safer than MAOIs but similar efficacy
AEs = nausea, agitation, confusion
Venlafaxine
SNRI
Reboxetine
NRI
Mirtazepine
NaSSA
Noradrenergic and specific serotonergic antidepressant
Trazodone
SARI
Serotonin antagonist and reuptake inhibitor
Lithium
Used for bipolar disorder as a mood stabiliser
Narrow therapeutic margin
Must check renal and thyroid function
AEs = thirst, nausea, fine tremor, polyuria, weight gain, oedema, acne
Drugs for short term insomnia
Lorazepam
Temazpam
= BZs with short half life
Drugs for long term insomnia
Z drugs
E.g. zolpidem, eszopiclone
Suvorexant
Dual orexin receptor antagonist
Can be used to treat insomnia
BZs used for anxiety
Clonazepam
Alprazolam
BZ MoA
Increase opening frequency of Cl- channels with GABA binding
Barbiturates MoA
Increase opening duration of Cl- channels with GABA binding
5-HT1a agonists
Buspirone
Ipsapirone
= partial agonists
Used in anxiety
Drug used in BZ overdose
Flumazenil
Antagonises BZ binding site
Short half-life so repeated dosing needed
Typical antipsychotics examples
Chlorpromazine
Fluphenazine
Haloperidol
Flupenthixol
Atypical antipsychotics examples
Risperidone
Olazanpine
Clozapine
Paliperidone
Targets of antipsychotics
Typical = D2 receptors Atypical = D2 + 5HT2, a1, H1, M so have more effect on negative and cognitive symptoms
Clozapine
Atypical antipsychotic
Highest affinity for D4 receptors
Drug of choice in treatment resistance
Risk of agranulocytosis